HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc > Q FOUR tomorrow before sunrise!

<< Previous

Bullboard Posts

Next >>

Post by pacer217on Mar 17, 2021 5:00pm

318 Views

Post# 32819257

Q FOUR tomorrow before sunrise!

The BEST case estimate from "experts " on CIBC post is a Break-even Q. @ .00 cents / share.

Longer term the prognosis is excellent; price guesses from $28. to above $40. within year.

Price action last two weeks suggests a "BEAT" before Thursday open.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market